UniProt ID | STAM2_HUMAN | |
---|---|---|
UniProt AC | O75886 | |
Protein Name | Signal transducing adapter molecule 2 | |
Gene Name | STAM2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 525 | |
Subcellular Localization |
Cytoplasm. Early endosome membrane Peripheral membrane protein Cytoplasmic side . |
|
Protein Description | Involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSL stimulation, it plays a role in signaling leading to DNA synthesis and MYC induction. May also play a role in T-cell development. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with HGS (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes (By similarity).. | |
Protein Sequence | MPLFTANPFEQDVEKATNEYNTTEDWSLIMDICDKVGSTPNGAKDCLKAIMKRVNHKVPHVALQALTLLGACVANCGKIFHLEVCSRDFATEVRAVIKNKAHPKVCEKLKSLMVEWSEEFQKDPQFSLISATIKSMKEEGITFPPAGSQTVSAAAKNGTSSNKNKEDEDIAKAIELSLQEQKQQHTETKSLYPSSEIQLNNKVARKVRALYDFEAVEDNELTFKHGEIIIVLDDSDANWWKGENHRGIGLFPSNFVTTNLNIETEAAAVDKLNVIDDDVEEIKKSEPEPVYIDEDKMDRALQVLQSIDPTDSKPDSQDLLDLEDICQQMGPMIDEKLEEIDRKHSELSELNVKVLEALELYNKLVNEAPVYSVYSKLHPPAHYPPASSGVPMQTYPVQSHGGNYMGQSIHQVTVAQSYSLGPDQIGPLRSLPPNVNSSVTAQPAQTSYLSTGQDTVSNPTYMNQNSNLQSATGTTAYTQQMGMSVDMSSYQNTTSNLPQLAGFPVTVPAHPVAQQHTNYHQQPLL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Phosphorylation | VEKATNEYNTTEDWS HHHHHHCCCCCCCHH | 21.63 | 27642862 | |
30 | Sulfoxidation | TEDWSLIMDICDKVG CCCHHHHHHHHHHHC | 3.26 | 30846556 | |
57 | Ubiquitination | IMKRVNHKVPHVALQ HHHHCCCCCHHHHHH | 52.86 | - | |
100 | Ubiquitination | VRAVIKNKAHPKVCE HHHHHHCCCCHHHHH | 42.97 | 21853274 | |
104 | Ubiquitination | IKNKAHPKVCEKLKS HHCCCCHHHHHHHHH | 50.04 | 33845483 | |
122 (in isoform 1) | Ubiquitination | - | 76.36 | 21890473 | |
122 | Ubiquitination | EWSEEFQKDPQFSLI HHHHHHHHCCCHHHH | 76.36 | 21906983 | |
122 (in isoform 2) | Ubiquitination | - | 76.36 | 21890473 | |
127 | Phosphorylation | FQKDPQFSLISATIK HHHCCCHHHHHHHHH | 21.39 | 27251275 | |
134 | Ubiquitination | SLISATIKSMKEEGI HHHHHHHHHHHHHCC | 39.89 | 23000965 | |
134 (in isoform 1) | Ubiquitination | - | 39.89 | 21890473 | |
134 (in isoform 2) | Ubiquitination | - | 39.89 | 21890473 | |
137 | Ubiquitination | SATIKSMKEEGITFP HHHHHHHHHHCCCCC | 60.76 | 23000965 | |
156 | Ubiquitination | QTVSAAAKNGTSSNK HHHHHHHHCCCCCCC | 51.70 | 21906983 | |
156 (in isoform 1) | Ubiquitination | - | 51.70 | 21890473 | |
156 (in isoform 2) | Ubiquitination | - | 51.70 | 21890473 | |
159 | Phosphorylation | SAAAKNGTSSNKNKE HHHHHCCCCCCCCHH | 38.07 | - | |
160 | Phosphorylation | AAAKNGTSSNKNKED HHHHCCCCCCCCHHH | 33.06 | - | |
161 | Phosphorylation | AAKNGTSSNKNKEDE HHHCCCCCCCCHHHH | 52.22 | - | |
163 | Ubiquitination | KNGTSSNKNKEDEDI HCCCCCCCCHHHHHH | 71.93 | 22817900 | |
165 (in isoform 1) | Ubiquitination | - | 69.06 | 21890473 | |
165 (in isoform 2) | Ubiquitination | - | 69.06 | 21890473 | |
165 | Ubiquitination | GTSSNKNKEDEDIAK CCCCCCCHHHHHHHH | 69.06 | 21906983 | |
172 | Ubiquitination | KEDEDIAKAIELSLQ HHHHHHHHHHHHHHH | 50.67 | 29967540 | |
177 | Phosphorylation | IAKAIELSLQEQKQQ HHHHHHHHHHHHHHH | 18.40 | 28555341 | |
182 | Ubiquitination | ELSLQEQKQQHTETK HHHHHHHHHHHCCCC | 51.69 | 21906983 | |
182 (in isoform 1) | Ubiquitination | - | 51.69 | 21890473 | |
182 (in isoform 2) | Ubiquitination | - | 51.69 | 21890473 | |
189 | Ubiquitination | KQQHTETKSLYPSSE HHHHCCCCCCCCCCH | 32.03 | 23000965 | |
189 (in isoform 2) | Ubiquitination | - | 32.03 | 21890473 | |
189 (in isoform 1) | Ubiquitination | - | 32.03 | 21890473 | |
190 | Phosphorylation | QQHTETKSLYPSSEI HHHCCCCCCCCCCHH | 40.32 | 28152594 | |
192 | Phosphorylation | HTETKSLYPSSEIQL HCCCCCCCCCCHHHH | 14.25 | 27273156 | |
194 | Phosphorylation | ETKSLYPSSEIQLNN CCCCCCCCCHHHHCH | 27.35 | 22210691 | |
195 | Phosphorylation | TKSLYPSSEIQLNNK CCCCCCCCHHHHCHH | 33.93 | 22210691 | |
202 | Ubiquitination | SEIQLNNKVARKVRA CHHHHCHHHHHHHHH | 35.88 | 23000965 | |
202 (in isoform 2) | Ubiquitination | - | 35.88 | 21890473 | |
202 (in isoform 1) | Ubiquitination | - | 35.88 | 21890473 | |
206 | Ubiquitination | LNNKVARKVRALYDF HCHHHHHHHHHHHCE | 26.74 | 23000965 | |
283 (in isoform 1) | Ubiquitination | - | 54.23 | 21890473 | |
283 (in isoform 2) | Ubiquitination | - | 54.23 | 21890473 | |
283 | Ubiquitination | DDDVEEIKKSEPEPV CCCHHHHHHCCCCCE | 54.23 | 21906983 | |
284 | Ubiquitination | DDVEEIKKSEPEPVY CCHHHHHHCCCCCEE | 66.76 | 33845483 | |
285 | Phosphorylation | DVEEIKKSEPEPVYI CHHHHHHCCCCCEEC | 54.07 | 28796482 | |
291 | Phosphorylation | KSEPEPVYIDEDKMD HCCCCCEECCHHHHH | 17.23 | 28796482 | |
296 | Ubiquitination | PVYIDEDKMDRALQV CEECCHHHHHHHHHH | 40.42 | 29967540 | |
343 | Ubiquitination | KLEEIDRKHSELSEL HHHHHHHHCHHHHHH | 47.97 | 30230243 | |
345 | Phosphorylation | EEIDRKHSELSELNV HHHHHHCHHHHHHHH | 43.18 | 28348404 | |
353 | Ubiquitination | ELSELNVKVLEALEL HHHHHHHHHHHHHHH | 39.78 | - | |
361 | Phosphorylation | VLEALELYNKLVNEA HHHHHHHHHHHHHCC | 10.81 | 23532336 | |
363 (in isoform 1) | Ubiquitination | - | 40.01 | 21890473 | |
363 | Ubiquitination | EALELYNKLVNEAPV HHHHHHHHHHHCCCH | 40.01 | 22817900 | |
371 | Phosphorylation | LVNEAPVYSVYSKLH HHHCCCHHCHHHCCC | 7.43 | 21945579 | |
372 | Phosphorylation | VNEAPVYSVYSKLHP HHCCCHHCHHHCCCC | 18.14 | 21945579 | |
374 | Phosphorylation | EAPVYSVYSKLHPPA CCCHHCHHHCCCCCC | 8.31 | 21945579 | |
375 | Phosphorylation | APVYSVYSKLHPPAH CCHHCHHHCCCCCCC | 26.95 | 21945579 | |
375 | O-linked_Glycosylation | APVYSVYSKLHPPAH CCHHCHHHCCCCCCC | 26.95 | 31373491 | |
418 | Phosphorylation | QVTVAQSYSLGPDQI EEEEEEEECCCCCCC | 8.88 | 25884760 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STAM2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STAM2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-192; TYR-371 ANDTYR-374, AND MASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-192 AND TYR-291, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-192, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-374, AND MASSSPECTROMETRY. | |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-371 AND TYR-374, ANDMASS SPECTROMETRY. |